Have a question?
Please get in touch with our team in case of any queries
INFERTILITY TREATMENT MARKET SIZE TO CROSS USD 7 BILLION BY 2024, GROWING AT A CAGR OF OVER 6% DURING FORECAST PERIOD
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
INFERTILITY TREATMENT MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (Revenue) | USD 7 Billion (2024) |
| CAGR | 6% (2019-2024) |
| Base Year | 2018 |
| Forecast Year | 2019- 2024 |
| Market Segments | Product (Drugs (Gonadotropins and Other Drugs) and Devices (Equipment, Media, and Consumables)), Procedure (Drug Therapy, ART Procedure, and Surgical Intervention) End-user (Clinics, Hospitals, Gynecological & Urology Clinics, and Others), Cause (Female and Male) |
| Geographic Analysis | Europe, North America, APAC, Latin America, and Middle East & Africa |
| Countries Covered | Spain, France, Germany, UK, Italy, Canada, US, China, Japan, South Korea, India, Australia, Brazil, Argentina, Mexico, Turkey, and Israel |
INDUSTRY INSIGHTS
The global infertility treatment market size will reach USD 7 billion in 2025, growing at a CAGR of 6% during the forecast period. The growing prevalence of infertility among men and women is increasing the demand for sterility treatment globally. Factors such as delayed parenthood, sexually transmitted infections (STIs), and aging is increasing sterility incidences among married couples worldwide. Hence, the treatment is likely to grow at a healthy rate due to attractive long-term growth from favorable demographics and social/cultural shifts.
Over the past few years, the infertility treatment market has been growing at a healthy rate. This growth is due to the growing awareness of several medical care options, IVF procedures, and the surge in fertility tourism. The popularity of same-sex marriage in the US increases the adoption of several assisted reproductive technology (ART) procedures.
The rise in the obese population is also positively influencing the growth of infertility treatment. Obesity might lead to ovulation disorder, imbalance in hormones, and, eventually, result in infertility. This increase in infertility has contributed to driving market growth globally.
SNIPPETS
- The increasing acceptance of advanced and sophisticated medical care options such as ART and IVF is likely to drive the market.
- The globalization of healthcare facilities and the increasing popularity of fertility tourism. This is encouraging several couples to travel abroad to seek state-of-the-art medical care options.
- The reimbursement coverage is also improving globally, and many countries cover fertility treatment as part of respective public health coverage programs.
- Most fertility service providers offer discounted programs and flexible payment options. These are promotional initiatives, promoting savings on expensive procedures to self-pay patients.
- The growing popularity of fertility tourism is expected to increase the demand for medical procedures in countries where the cost is low and success rates are high, thereby driving the segment.
INFERTILITY TREATMENT MARKET SEGMENTATION
This research report includes detailed segmentation by
- Product
- Procedure
- End-user
- Cause
- Geography
INSIGHTS BY PRODUCT
Treatment by drugs has been dominating the infertility treatment market share. This method is a cost-effective measure and is considered the first choice among people to be treated. The acceptance of gonadotropin drugs for treatment is driving the segment significantly. It is likely to witness steady growth during the forecast period.
Globally, the IVF treatments are witnessing an improvement in overall success rates majorly due to the availability of a broad range of culture media. The consumables segment is rapidly increasing. The increasing effectiveness of ART procedures and surgical interventions creates a huge demand for consumables. Therefore, the consumables segment is expected to grow by 2024.
INSIGHTS BY PROCEDURE
The medication market segment accounted for a market share of 73% in 2018. The medication segment is the largest contributor due to a wide range and usage. The increasing approval of fertility services and cultural shifts has led to high demand for medication and treatments. The awareness of sterility treatment has increased over time, thereby reducing the reluctance of people to opt for medication.
ART is the fastest growing procedure. The high acceptance rate is because of the improvement in success rate and advanced techniques to cure sterility. ART procedures include different procedures like artificial insemination, in-vitro fertilization IVF, surrogacy, and others. The favorable financial support for ART procedures in both developed and emerging countries is another factor contributing to the growth. However, the segment is likely to witness hindrance due to the high cost of ART procedures.
The surgical interventions segment is expected to witness gradual growth by 2024. Surgical interventions are considered as the second line of care after medication. This segment is likely to see an incremental growth of around $200 million during the forecast period.
INSIGHTS BY END-USER
Fertility clinics dominate the market due to the high success rate of fertility services and IVF clinics. The number of fertility centers is expanding across the globe. These clinics occupy the largest share in the infertility treatment market.
Fertility centers offer different services, such as IVF programs, egg donation, ICSI, IMSI, and other services. The segment is projected to hold the highest share during the forecast period. This is due to the constant rise in clinics and increasing partnership of clinics with fertile consultants and experts.
Hospitals are a significantly fast-growing segment. They provide traditional medical care, such as fertility medicines, drugs, prescriptions, and surgeries. They also facilitate procedures such as IVF and ART, which are likely to have significant demand during the forecast period.
Gynecologists and urologist clinics offer high-quality women’s healthcare services, including labor care, and prescribe medication for fertility treatment. They are primary healthcare centers performing preliminary fertility evaluations among end-users. Hence, this segment is expected to grow at a steady growth during the forecast period.
INSIGHTS BY CAUSES
The female segment is contributing significantly to the market due to the high prevalence of female infertility globally. The increase in the target pool of female patients and the growing fertility clinics are the major factors driving the growth. The rise in the number of obese women is likely to increase the demand for various fertility treatment options.
The prevalence of male sterility is increasing worldwide due to changes in lifestyle patterns. Increase in the consumption of alcohol and smoking, and an increase in the prevalence of obesity are the responsible factors. All these factors affect sperm counts and their quality, thereby increasing the occurrence among men.
INSIGHTS BY GEOGRAPHY
Europe is leading the market and is expected to bolster its dominance during the forecast period. The region is going through a phase of reduction in population and is seriously considering tackling this sociological phenomenon. Spain, France, Germany, the UK, and Italy are the leading revenue generators. The region will witness an incremental growth of around $600 million during the forecast period.
The demand for fertility services is increasing rapidly in North America. The rise is due to the growing prevalence of sterility, the presence of the aging population, and obesity. These factors are likely to generate significant demand for fertility services in the future.
APAC is growing at a steady pace. The shifting mean age among women during their first childbirth and the increasing sterility is driving the market growth. Japan, Australia, China, and India are the major revenue contributors in the APAC region. This region is likely to witness the highest incremental revenues during the forecast period.
Latin America is witnessing a rise in sterility among men and women. The decreasing fertility rates in the population is likely to increase the demand for fertility services. The region is growing at a moderate pace, which is likely to continue during the forecast period.
MEA faces a low healthcare facility, a lack of specialized health care professionals, and inadequate awareness of fertility medical care. However, the growing awareness and development of advanced technology are expected to drive the infertility treatment market share in the region.
INSIGHTS BY VENDORS
There are a few global and several local and regional key players offering medicines, devices, and treatment equipment. The fertility drug market is highly concentrated, with key pharmaceuticals accounting for commendable shares. However, the other fertility drugs market is highly fragmented. Many local and domestic companies are offering a wide array of low-cost drugs in their respective countries.
The market is competitive due to the availability of several low-cost drugs. Companies offering fertility drugs are registering impressive growth rates for their products due to the increased uptake of these drugs.
Cooper Companies offers its infertility treatment products through the CooperSurgical business segment. Cooper is focusing on specific segments of women’s health care market and is the market leader. Its major competitors in the market include Cook, Irvine Scientific, and Vitrolife.
The global infertility treatment market research report includes revenues & forecasts for the following segments:
By Product
- Drugs
- Gonadotropins
- Other Drugs
- Devices
- Equipment
- Media
- Consumables
By Procedure
- Drug Therapy
- ART Procedure
- Surgical Intervention
By End-user
- Clinics
- Hospitals
- Gynecological & Urology Clinics
- Others
By Cause
- Female
- Male
- Others
By Geography
- Europe
- Spain
- France
- Germany
- UK
- Italy
- North America
- Canada
- US
- APAC
- China
- Japan
- South Korea
- India
- Australia
- Latin America
- Brazil
- Argentina
- Mexico
- Middle East & Africa
- Turkey
- Israel
Frequently Asked Questions
What is the Infertility Treatment Market size and growth rate during the forecast period?
What are the factors impacting the growth of the Infertility Treatment Market share?
How is the growth prospects of the infertility treatment market in Europe?
Who are the leading vendors and what is their market share?
What is the growth of the medication segment during the forecast period?
The infertility treatment market is expected to grow at a CAGR of over 6% during the forecast period 2018–2024.
The following factors are likely to contribute to the growth of the infertility treatment market during the forecast period:
- Increasing Prevalence of Infertility
- Growing Number of Obesity Cases
- Increasing Number of Facilities offering Fertility Services
- Increasing Financial Assistance Programs
- Growing popularity for Fertility Tourism
Base Year: 2018
Forecast Year: 2019–2024
The study considers the present scenario of the global infertility treatment market and its market dynamics for the period 2018−2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
- The Cooper Companies
- Business Overview
- Major Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- Cook Medical
- Vitrolife
- Ferring Pharmaceuticals
- IVFtech
- Irvine Scientific
- Merck KGaA
Other Vendors
- Abbott
- Business Overview
- Major Product Offerings
- Sanofi
- Salix Pharmaceuticals
- Microtech IVF
- Novartis
- Hamilton Thorne
- The Merck Co
- Thermo Fisher Scientific
- INVO Bioscience
- MedGyn Products
- SOMATEX Medical Technologies
- CARL ZEISS
Market Segmentation by Product
- Drugs
- Gonadotropins
- Other Drugs
- Devices
- Equipment
- Media
- Consumables
Market Segmentation by Procedure
- Drug Therapy
- ART Procedure
- Surgical Intervention
Market Segmentation by End-user
- Infertility Clinics
- Hospitals
- Gynecological & Urology Clinics
- Others
Market Segmentation by Cause
- Female Infertility
- Male Infertility
- Others
Market Segmentation by Geography
- Europe
- Spain
- France
- Germany
- UK
- Italy
- North America
- Canada
- US
- APAC
- China
- Japan
- South Korea
- India
- Australia
- Latin America
- Brazil
- Argentina
- Mexico
- MEA
- Turkey
- Israel
List of Exhibits
Exhibit 1 Segmentation of Global Infertility Treatment Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 5-year Primary Infertility Rate Among Males & Females
Exhibit 4 5-year Secondary Infertility Rate Among Males & Females
Exhibit 5 Causes of Infertility
Exhibit 6 Global Infertility Treatment Market by Product 2018 (%)
Exhibit 7 Global Infertility Treatment Market by Geography 2018 (%)
Exhibit 8 Impact of Increasing Prevalence of Infertility
Exhibit 9 Couples Affected by Infertility Worldwide from 1990−2010 (million)
Exhibit 10 Six Demographic Realities of Infertility
Exhibit 11 Share of Primary and Secondary Fertility Among Couples Worldwide
Exhibit 12 Cause of Infertility Among Couples by Region 2015 (%)
Exhibit 13 Percentage of Infertile Married Women in US 2002−2015
Exhibit 14 Share of Infertile Women with Infection-related Diagnosis by Region
Exhibit 15 Mean Age of Women Having Their First Child in Developed and Developing Countries
Exhibit 16 Impact of Rising Number of Obesity Cases
Exhibit 17 Number of Obese Adults by Gender 2016 (million)
Exhibit 18 Prevalence Rate of Obesity in Men and Women 2016
Exhibit 19 Worldwide Number of Obese Adults 1975 Versus 2016 (million)
Exhibit 20 Worldwide Prevalence of Obesity Among Adults by Region 2016
Exhibit 21 Impact of Increasing Acceptance of ART Procedures
Exhibit 22 Global Number of ART Cycles Performed 2007 Versus 2018
Exhibit 23 Number of ART Cycles Performed by Region 2018
Exhibit 24 Impact of Increasing Number of Facilities Offering Fertility Services
Exhibit 25 Percentage Share of ART Cycles Performed by Region 2018
Exhibit 26 Share of Stand-alone Fertility Care Centers by Region 2017
Exhibit 27 Impact of High Cost of Treatment
Exhibit 28 Average Cost of Single IVF Cycle in Various Countries ($)
Exhibit 29 Impact of Lack of Standardized Government Regulations on Treatment
Exhibit 30 Major Legal Differences Between Countries for Treatment
Exhibit 31 Impact of Ethical Challenges Related to Treatment
Exhibit 32 Impact of Limitations & Risks Associated with Treatment
Exhibit 33 Limitations & Risks Associated with Treatment
Exhibit 34 Cumulative Pregnancy Rate of IVF Procedure
Exhibit 35 Impact of Financial Assistance Programs & Employer Benefits for Treatment
Exhibit 36 Impact of Growing Popularity of Fertility/Reproductive Tourism
Exhibit 37 Factors Influencing Patients to Consider Fertility Tourism
Exhibit 38 Impact of Technological Advancements & Innovations
Exhibit 39 Impact of Acceptance of Treatment in Single Parents & Same-Sex Couples
Exhibit 40 Same-Sex Married Couples in US Between 2004-2014 Period
Exhibit 41 Global Infertility Treatment Market 2018−2024 ($ million)
Exhibit 42 Market by Procedure
Exhibit 43 Market by Product Type
Exhibit 44 Market by Geography
Exhibit 45 Market by Cause
Exhibit 46 Market by End-users
Exhibit 47 Five Forces Analysis 2018
Exhibit 48 Incremental Growth by Product 2018–2024
Exhibit 49 Market by Product
Exhibit 50 Market by Product 2018−2024 ($ million)
Exhibit 51 Market by Product 2018−2024 (%)
Exhibit 52 Global Infertility Drugs Treatment Market 2018−2024 ($ million)
Exhibit 53 Global Gonadotropins Market 2018-2024 ($ million)
Exhibit 54 Global Infertility Other Drugs Treatment Market 2018-2024 ($ million)
Exhibit 55 Market by Region 2018 & 2024 (%)
Exhibit 56 Market by Region 2018-2024 ($ million)
Exhibit 57 Market by Region 2018-2024 (%)
Exhibit 58 Global Infertility Devices Market 2018−2024 ($ million)
Exhibit 59 Global Infertility Equipment Market 2018-2024 ($ million)
Exhibit 60 Global Infertility Treatment Media Market 2018-2024 ($ million)
Exhibit 61 Global Infertility Treatment Consumables & Accessories Market 2018-2024 ($ million)
Exhibit 62 Market by Region 2018 & 2024 (%)
Exhibit 63 Market by Region 2018-2024 ($ million)
Exhibit 64 Market by Region 2018-2024 (%)
Exhibit 65 Incremental Growth by Cause 2018-2024
Exhibit 66 Market by Cause
Exhibit 67 Market by Cause 2018 & 2024 (%)
Exhibit 68 Market by Cause 2018−2024 ($ million)
Exhibit 69 Market by Cause 2018−2024 (%)
Exhibit 70 5-year Female Factor Contribution to Primary Infertility Cases
Exhibit 71 Global Female Infertility Treatment Market 2018−2024 ($ million)
Exhibit 72 5-year Female Factor Contribution to Secondary Infertility Cases
Exhibit 73 5-year Male Factor Contribution to Primary Infertility Cases
Exhibit 74 Percentage Share of Major Causes of Male Infertility
Exhibit 75 5-year Male Factor Contribution to Secondary Infertility Cases
Exhibit 76 Global Male Infertility Treatment Market 2018−2024 ($ million)
Exhibit 77 Global Other Infertility Treatment Market 2018−2024 ($ million)
Exhibit 78 Percentage Share of Couples Reported Infertile by Region
Exhibit 79 Incremental Growth by Procedure 2018−2024
Exhibit 80 Market by Procedure
Exhibit 81 Market by Procedure 2018 & 2024 (%)
Exhibit 82 Market by Procedure 2018−2024 ($ million)
Exhibit 83 Market by Procedure 2018−2024 (%)
Exhibit 84 Global Infertility Medication Market 2018−2024 ($ million)
Exhibit 85 Adults with Obesity Worldwide
Exhibit 86 Cost Comparison of IVF and Surrogacy
Exhibit 87 Global ART Infertility Treatment Market 2018−2024 ($ million)
Exhibit 88 Global Infertility Surgical Intervention Market 2018−2024 ($ million)
Exhibit 89 Incremental Growth by End-users 2018−2024
Exhibit 90 Market by End-user
Exhibit 91 Market by End-user 2018 & 2024 (%)
Exhibit 92 Market by End-user 2018−2024 ($ million)
Exhibit 93 Market by End-user 2018−2024 (%)
Exhibit 94 Global Fertility Clinics Market 2018−2024 ($ million)
Exhibit 95 Global Infertility Treatment Hospitals Market 2018−2024 ($ million)
Exhibit 96 Global Infertility Gynecology Clinic Market 2018−2024 ($ million)
Exhibit 97 Global Other Infertility Treatment Market 2018−2024 ($ million)
Exhibit 98 Incremental Growth by Geography 2018−2024
Exhibit 99 Market by Region
Exhibit 100 Market by Region 2018 & 2024 (%)
Exhibit 101 Market by Region 2018−2024 ($ million)
Exhibit 102 Market by Region 2018−2024 (%)
Exhibit 103 Market in Europe: Key Countries Share 2018 (%)
Exhibit 104 Percentage Share of Certified IVF & Fertility Clinics by Region 2018
Exhibit 105 Market in Europe 2018–2024 ($ million)
Exhibit 106 Market in Europe by Product 2018 & 2024 (%)
Exhibit 107 Market in Europe by Product 2018-2024 (%)
Exhibit 108 Market in Europe by Product 2018-2024 (%)
Exhibit 109 Incremental Growth in Europe 2018−2024
Exhibit 110 Market in Spain 2018–2024 ($ million)
Exhibit 111 Market in France 2018–2024 ($ million)
Exhibit 112 Market in Germany 2018–2024 ($ million)
Exhibit 113 Market in UK 2018–2024 ($ million)
Exhibit 114 Market in Italy 2018–2024 ($ million)
Exhibit 115 Market in North America: Key Countries Share 2018 (%)
Exhibit 116 Percentage Share of ART Cycles Performed in North America by Countries 2018
Exhibit 117 Infertility Rate Among Women Based on Age in North America 2018 (%)
Exhibit 118 Percentage of Infertile Married Women in 15−44 Age Group
Exhibit 119 Market in North America 2018–2024 ($ million)
Exhibit 120 Market in North America by Product 2018 & 2024 (%)
Exhibit 121 Market in North America by Product 2018-2024 (%)
Exhibit 122 Market in North America by Product 2018-2024 (%)
Exhibit 123 Incremental Growth in North America 2018−2024
Exhibit 124 Share of Adult People with Obesity in US 2012
Exhibit 125 Estimated Share of Adult People with Obesity in US 2030
Exhibit 126 Market in US 2018–2024 ($ million)
Exhibit 127 Number of Infants Born and ART Procedures Performed in US (2002−2012)
Exhibit 128 Percentage Share of ART Cycles Based on Age Group 2018 (%)
Exhibit 129 Market in Canada 2018–2024 ($ million)
Exhibit 130 Market in APAC: Key Countries Share 2018 (%)
Exhibit 131 Percentage Share of ARTs Performed in Various Regions
Exhibit 132 Market in APAC 2018–2024 ($ million)
Exhibit 133 Market in APAC by Product 2018 & 2024 (%)
Exhibit 134 Market in APAC by Product 2018-2024 (%)
Exhibit 135 Market in APAC by Product 2018-2024 ($million)
Exhibit 136 Incremental Growth in APAC 2018−2024
Exhibit 137 Market in Japan 2018–2024 ($ million)
Exhibit 138 Market in Australia 2018–2024 ($ million)
Exhibit 139 Market in China 2018–2024 ($ million)
Exhibit 140 Market in India 2018–2024 ($ million)
Exhibit 141 Market in Latin America: Key Countries Share 2018 (%)
Exhibit 142 Lifetime Births Per Women in Key Latin American Countries
Exhibit 143 Market in Latin America 2018–2024 ($ million)
Exhibit 144 Market in Latin America by Product 2018 & 2024 (%)
Exhibit 145 Market in Latin America by Product 2018-2024 ($million)
Exhibit 146 Market in Latin America by Product 2018-2024 (%)
Exhibit 147 Incremental Growth in Latin America 2018−2024
Exhibit 148 Market in Brazil 2018–2024 ($ million)
Exhibit 149 Market in Argentina 2018–2024 ($ million)
Exhibit 150 Market in Mexico 2018–2024 ($ million)
Exhibit 151 Market in MEA: Key Countries Share 2018 (%)
Exhibit 152 Market in MEA 2018–2024 ($ million)
Exhibit 153 Market in MEA by Product 2018 & 2024 (%)
Exhibit 154 Market in MEA by Product 2018-2024 ($ million)
Exhibit 155 Market in MEA by Product 2018-2024 (%)
Exhibit 156 Incremental Growth in MEA 2018−2024
Exhibit 157 Market in Turkey 2018–2024 ($ million)
Exhibit 158 Market in Israel 2018–2024 ($ million)
Exhibit 159 CooperSurgical Revenue Breakdown by category FY2018 (%)
Exhibit 160 Vitrolife Sales Breakdown by Business Segment 2018
Exhibit 161 Merck KGaA Fertility Product Line Revenue 2018 & 2017 ($ million)
Exhibit 162 The Cooper Companies Sales Revenue 2018-2016 ($ million)
Exhibit 163 The Cooper Companies Sales Revenue by Business Segment 2018 & 2017 ($ million)
Exhibit 164 The Cooper Companies Sales Revenue by Business Segment 2018 & 2017 ($ million)
Exhibit 165 The Cooper Companies R&D Expenditure 2016-2018 ($ million)
Exhibit 166 Vitrolife Sales Revenue 2018–2016 ($ million)
Exhibit 167 Vitrolife Sales Revenue by Business Segment 2018 & 2017 ($ million)
Exhibit 168 Vitrolife Sales Breakdown by Business Segment 2018
Exhibit 169 Vitrolife Sales Breakdown by Geography 2018
Exhibit 170 Merck KGaA Sales Revenue 2016−2018 ($ million)
Exhibit 171 Merck KGaA Sales Revenue by Business Segments 2018 & 2017 ($ million)
Exhibit 172 Merck KGaA Sales Breakdown by Business Segment 2018
Exhibit 173 Merck KGaA Sales Breakdown by Geography 2018
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Effects of Adipokines on Reproduction
Table 4 Chances of a Live Birth by Fifth IVF Cycle
Table 5 Cost of Various Treatment Options
Table 6 Estimated Cost of IVF Treatment in Various Countries
Table 7 Ethical and Legal Challenges Prevailing in Various Countries
Table 8 Pregnancy Rate Among Women Undergoing IVF
Table 9 Pregnancy Rate Among Women Undergoing ICSI
Table 10 Pregnancy Rate Among Women Donor Eggs & Embryos
Table 11 Financial Assistance Programs for Treatment
Table 12 Major Destinations for Fertility Tourism
Table 13 New Developments/Advancements in Treatment
Table 14 List of Major Countries Allowing Same-sex Marriage
Table 15 Available Treatment Options for Single Women to Conceive
Table 16 Popular Infertility Treatment Drugs Commercially Available
Table 17 Different Types of Microscopes used in ART Procedures
Table 18 Different Types of Imaging Modalities Used in ART Procedures
Table 19 Mean Age of Women at First Birth by Key Countries
Table 20 Major Drugs Prescribed for Infertility
Table 21 Global List of Popular Fertility Clinics
Table 22 List of Popular Cryobanks Offering Storage of Sperms, Eggs, and Embryos
Table 23 Competitive Structure Analysis of Global Infertility Treatment Market 2018
Table 24 Global Infertility Treatment Market by Drugs: Key Vendors Ranking 2018
Table 25 Global Infertility Treatment Market by Devices: Key Vendors Ranking 2018
Table 26 The Cooper Companies: Product Offerings
Table 27 Cook Medical: Fields of Applications
Table 28 Cook Medical: Product Offerings
Table 29 Vitrolife: Product Offerings
Table 30 Ferring Pharmaceuticals: Product Offerings
Table 31 IVFtech: Product Offerings
Table 32 FUJIFILM Irvine Scientific: Product Offerings
Table 33 Merck KGaA: Product Offerings
Table 34 Abbott: Key Product Offerings
Table 35 Sanofi: Key Product Offerings
Table 36 Salix Pharmaceuticals: Key Product Offerings
Table 37 Microtech IVF: Key Product Offerings
Table 38 Novartis: Key Product Offerings
Table 39 Hamilton Thorne: Key Product Offerings
Table 40 Merck Co: Key Product Offerings
Table 41 Thermo Fisher Scientific: Key Product Offerings
Table 42 INVO Bioscience: Key Product Offerings
Table 43 MedGyn Products: Key Product Offerings
Table 44 SOMATEX Medical Technologies: Key Product Offerings
Table 45 CARL ZEISS: Key Product Offerings
Table 46 Market by Products ($ million)
Table 47 Market by Products (%)
Table 48 Market by Procedure ($ million)
Table 49 Market by Applications (%)
Table 50 Market by Cause ($ million)
Table 51 Market by Cause (%)
Table 52 Market by End-users ($ million)
Table 53 Market by End-users (%)
Table 54 Market by Geography ($ million)
Table 55 Market by Geography (%)
Table 56 Market by Drugs ($ million)
Table 57 Market by Drugs (%)
Table 58 Market by Devices ($ million)
Table 59 Market by Devices (%)
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Infertility Cause
4.4.3 Market Segmentation by Procedure
4.4.4 Market Segmentation by End-users
4.4.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Infertility: An Overview
7.1.1 Symptoms
7.1.2 Causes
7.1.3 Infertility Treatment
7.2 Infertility Treatment: Global Market Snapshot
7.2.1 Overview
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increasing Prevalence of Infertility
8.1.2 Rising Number of Obesity Cases
8.1.3 Increasing Acceptance of ART Procedures
8.1.4 Increasing Number of Facilities Offering Fertility Services
8.2 Market Growth Restraints
8.2.1 High Cost of Infertility Treatment
8.2.2 Lack of Standardized Government Regulations on Treatment
8.2.3 Ethical Challenges Related to Treatment
8.2.4 Limitations & Risks Associated with Treatment
8.3 Market Opportunities & Trends
8.3.1 Financial Assistance Programs & Employer Benefits for Treatment
8.3.2 Growing Popularity of Fertility/Reproductive Tourism
8.3.3 Technological Advancements & Innovations
8.3.4 Acceptance of Infertility Treatment in Single Parents & Same-Sex Couples
9 Global Infertility Treatment Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Infertility Treatment Market by Product
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
11 Infertility Treatment Market by Drugs
11.1 Market Overview
11.1.1 Market Size & Forecast
11.2 Gonadotropins
11.2.1 Market Overview
11.2.2 Market Size & Forecast
11.3 Other Drugs
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Infertility Drugs: Market Segmentation by Region
11.4.1 Overview
12 Infertility Treatment Market by Devices
12.1 Market Overview
12.1.1 Market Size & Forecast
12.2 Equipment
12.2.1 Market Overview
12.2.2 Market Size & Forecast
12.3 Media
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Consumables & Accessories
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Infertility Treatment Devices: Segmentation by Region
12.5.1 Overview
13 Infertility Treatment Market by Cause
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Female Infertility
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Male Infertility
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Other Types of Infertility
13.5.1 Market Overview
13.5.2 Market Size & Forecast
14 Infertility Treatment Market by Procedure
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Medication
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Assisted Reproductive Treatment
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Surgical Intervention
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 Infertility Treatment Market by End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Fertility Clinics
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Hospitals
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Gynecology & Urology Clinics
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Other End-users
15.6.1 Market Overview
15.6.2 Market Size & Forecast
16 Infertility Treatment Market by Geography
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Market Segmentation by Product Type
17.3.1 Overview
17.4 Key Countries
17.4.1 Spain: Market Size & Forecast
17.4.2 France: Market Size & Forecast
17.4.3 Germany: Market Size & Forecast
17.4.4 UK: Market Size & Forecast
17.4.5 Italy: Market Size & Forecast
18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Market Segmentation by Product Type
18.3.1 Overview
18.4 Key Countries
18.4.1 US: Market Size & Forecast
18.4.2 Canada: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Market Segmentation by Product Type
19.3.1 Overview
19.4 Key Countries
19.4.1 Japan: Market Size & Forecast
19.4.2 Australia: Market Size & Forecast
19.4.3 China: Market Size & Forecast
19.4.4 India: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Market Segmentation by Product Type
20.3.1 Overview
20.4 Key Countries
20.4.1 Brazil: Market Size & Forecast
20.4.2 Argentina: Market Size & Forecast
20.4.3 Mexico: Market Size & Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Market Segmentation by Product Type
21.3.1 Overview
21.4 Key Countries
21.4.1 Turkey: Market Size & Forecast
21.4.2 Israel: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Vendors Market Share Analysis
22.2.1 The Cooper Companies
22.2.2 Cook Medical
22.2.3 Vitrolife
22.2.4 Ferring Pharmaceuticals
22.2.5 Merck KGaA
22.2.6 IVFtech
23 Key Company Profiles
23.1 The Cooper Companies
23.1.1 Business Overview
23.1.2 Major Product Offerings
23.1.3 Key Strengths
23.1.4 Key Strategies
23.1.5 Key Opportunities
23.2 Cook Medical
23.2.1 Business Overview
23.2.2 Major Product Offerings
23.2.3 Key Strengths
23.2.4 Key Strategies
23.2.5 Key Opportunities
23.3 Vitrolife
23.3.1 Business Overview
23.4 Major Product Offerings
23.4.1 Key Strengths
23.4.2 Key Strategies
23.4.3 Key Opportunities
23.5 Ferring Pharmaceuticals
23.5.1 Business Overview
23.5.2 Major Product Offerings
23.5.3 Key Strengths
23.5.4 Key Strategies
23.5.5 Key Opportunities
23.6 IVFtech
23.6.1 Business Overview
23.6.2 Major Product Offerings
23.6.3 Key Strengths
23.6.4 Key Strategies
23.6.5 Key Opportunities
23.7 FUJIFILM Irvine Scientific
23.7.1 Business Overview
23.7.2 Major Product Offerings
23.7.3 Key Strengths
23.7.4 Key Strategies
23.7.5 Key Opportunities
23.8 Merck KGaA
23.8.1 Business Overview
23.8.2 Major Product Offerings
23.8.3 Key Strengths
23.8.4 Key Strategies
23.8.5 Key Opportunities
24 Other Prominent Vendors
24.1 Abbott
24.1.1 Business Overview
24.1.2 Major Product Offerings
24.2 Sanofi
24.2.1 Business Overview
24.2.2 Major Product Offerings
24.3 Salix Pharmaceuticals
24.3.1 Business Overview
24.3.2 Major Product Offerings
24.4 Microtech IVF
24.4.1 Business Overview
24.4.2 Major Product Offering
24.5 Novartis
24.5.1 Business Overview
24.5.2 Major Product Offerings
24.6 Hamilton Thorne
24.6.1 Business Overview
24.6.2 Major Product Offering
24.7 Merck Co
24.7.1 Business Overview
24.7.2 Major Product Offerings
24.8 Thermo Fisher Scientific
24.8.1 Business Overview
24.8.2 Major Product Offerings
24.9 INVO Bioscience
24.9.1 Business Overview
24.9.2 Major Product Offerings
24.10 MedGyn Products
24.10.1 Business Overview
24.10.2 Major Product Offerings
24.11 SOMATEX Medical Technologies
24.11.1 Business Overview
24.11.2 Major Product Offerings
24.12 Carl Zeiss
24.12.1 Business Overview
24.12.2 Major Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
25.3 Quantitative Summary
25.3.1 By Product
25.3.2 By Procedure
25.3.3 By Infertility Cause
25.3.4 By End-user
25.3.5 By Geography
25.3.6 By Drugs
25.3.7 By Devices
26 Appendix
26.1 Abbreviations
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the Infertility Treatment Market size and growth rate during the forecast period?
What are the factors impacting the growth of the Infertility Treatment Market share?
How is the growth prospects of the infertility treatment market in Europe?
Who are the leading vendors and what is their market share?
What is the growth of the medication segment during the forecast period?
Other RELATED Reports
Erectile Dysfunction Market - Global Outlook and Forecast 2018-2023
Published : February 2018
Premature Ejaculation Therapeutics Market - Global Outlook and Forecast 2020-2025
Published : March 2020
